tiprankstipranks
9 Meters Biopharma, Inc. (NMTRQ)
:NMTRQ
US Market

9 Meters Biopharma (NMTRQ) Income Statement

Compare
1,968 Followers

9 Meters Biopharma Income Statement

Last quarter (Q1 2023), 9 Meters Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, 9 Meters Biopharma's net income was $-13.87M. See 9 Meters Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 8.52K$ 7.57K$ 18.49K$ -21.61K$ -19.55K
EBITDA
$ -39.30M$ -36.72M$ -57.43M$ -24.21M$ -15.48M
Operating Income
$ -42.02M$ -36.76M$ -60.88M$ -25.58M$ -18.22M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -43.77M$ -36.78M$ -61.50M$ -27.13M$ -24.16M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

9 Meters Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis